Market Momentum Report: Gyre Therapeutics Inc (GYRE)’s Positive Close at 10.18

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

The price of Gyre Therapeutics Inc (NASDAQ: GYRE) closed at $10.18 in the last session, up 17.28% from day before closing price of $8.68. In other words, the price has increased by $17.28 from its previous closing price. On the day, 1.98 million shares were traded.

Ratios:

We take a closer look at GYRE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.60. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.

On February 10, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $15.Piper Sandler initiated its Overweight rating on February 10, 2021, with a $15 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 22 ’25 when Ma Songjiang sold 2,000 shares for $10.97 per share. The transaction valued at 21,940 led to the insider holds 2,808,824 shares of the business.

Ma Songjiang sold 182 shares of GYRE for $1,864 on May 23 ’25. The President now owns 2,808,642 shares after completing the transaction at $10.24 per share. On May 20 ’25, another insider, Ma Songjiang, who serves as the President of the company, sold 2,000 shares for $11.25 each. As a result, the insider received 22,500 and left with 2,812,824 shares of the company.

Valuation Measures:

As of this moment, Gyre’s Price-to-Earnings (P/E) ratio for their current fiscal year is 212.53, and their Forward P/E ratio for the next fiscal year is 8.70. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.14 while its Price-to-Book (P/B) ratio in mrq is 13.10.

Stock Price History:

Over the past 52 weeks, GYRE has reached a high of $19.00, while it has fallen to a 52-week low of $6.11. The 50-Day Moving Average of the stock is 11.35%, while the 200-Day Moving Average is calculated to be -11.26%.

Shares Statistics:

A total of 87.64M shares are outstanding, with a floating share count of 15.86M. Insiders hold about 85.25% of the company’s shares, while institutions hold 2.96% stake in the company.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.